Relay Therapeutics Reports Second Quarter 2025 Financial Results and Corporate Updates GlobeNewswire August 07, 2025 Presented updated data at ASCO showing consistency with prior data, including 10.3-month median PFS and 39% ORR in patients with PI3Kα-mutated, HR+/HER2- metastatic breast cancer Initiated Phase 3 ReDiscover-2 trial in Q2 Approximately $657 million in cash, cash equivalents and […]
Runway Growth Finance Corp. Reports Second Quarter 2025 Financial Results GlobeNewswire August 07, 2025 Delivered Total and Net Investment Income of $35.1 million and $13.9 million, Respectively Investment Portfolio of $1.0 billion Conference Call Today, Thursday, August 7, 2025 at 5:00 p.m. ET MENLO PARK, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) — Runway Growth Finance
94% Revenue Growth in Evolve™ Rodent Birth Control Products Strong Cash Balance and Sustained Progress Toward Profitability SenesTech, Inc. (NASDAQ: SNES), the leader in fertility control for managing animal pest populations and the only manufacturer of EPA-registered rodent birth control products today announced its financial results for the second quarter ended June30, 2025. https://mma.prnewswire.com/media/1503420/SenesTech_Logo.jpg Q2
Announced Strategic Partnership with Grocery Logistics Leader IFCO to Digitize their Global RPC Pool Completed Transfer of Production from Singapore to State-of-the-art Thailand Facility Launched Partnership with Narravero to Accelerate Digital Product Passport Adoption and Compliance Identiv, Inc. (NASDAQ: INVE), a global leader in RFID- and BLE-enabled Internet of Things (IoT) solutions, today released its
Gen Raises its Annual Guidance on Better-Than-Expected Results Gen Digital Inc. (NASDAQ: GEN), a global leader dedicated to powering Digital Freedom, released its results for its first quarter fiscal year 2026, which ended July 4, 2025. https://mma.prnewswire.com/media/2745858/Gen_Q1FY26_Earnings.jpg “FY26 is off to a strong start, with Q1 results beating expectations,” said Vincent Pilette, CEO of Gen.
(NASDAQ:OMDA), Revenue of $61 million, up 49%52% Member Growth and Significant Progress Toward Profitability SAN FRANCISCO, Aug. 07, 2025 (GLOBE NEWSWIRE) — Omada Health, Inc. (Nasdaq: OMDA), the virtual between-visit healthcare provider, today reported financial results for the second quarter ended June 30, 2025. 2025 Second Quarter Highlights Total Members of 752,000, up 52% compared
(NASDAQ:BACK), Project will leverage Ignite Proteomics' reverse-phase protein array (RPPA) platform to profile tumor-immune signaling in breast-cancer samples Golden, CO, Aug. 07, 2025 (GLOBE NEWSWIRE) — Ignite Proteomics LLC, a subsidiary of IMAC Holdings, Inc. (OTCQB: BACK), today announced a one-year research collaboration with Vanderbilt University Medical Center (VUMC) to characterize protein-signaling pathways that help
(NASDAQ:CDTX), Phase 2b NAVIGATE clinical trial evaluating CD388 for the prevention of seasonal influenza met primary and all secondary efficacy endpoints for all dose groups End of Phase 2 meeting request submitted to the U.S. Food and Drug Administration (FDA) Closed upsized public offering for gross proceeds of $402.5 million; significantly strengthened balance sheet to
Second Quarter 2025 Revenue was $513.6 Million Net Loss was $6.7 Million or negative 1.3 Percent of Revenue (Net Income of $10.6 Million or 2.1 Percent of Revenue Non-GAAP) Adjusted EBITDA was $51.8 Million or 10.1 Percent of Revenue Updates Revenue Outlook for Full Year 2025 TTEC Holdings, Inc. (NASDAQ:TTEC), a leading global CX (customer
(NASDAQ:JYNT), – Refranchised 37 clinics; Franchises now represent 92% of the portfolio – – Acquired rights to the Northwest regional developer territory – SCOTTSDALE, Ariz., Aug. 07, 2025 (GLOBE NEWSWIRE) — The Joint Corp. (NASDAQ: JYNT), a national operator, manager, and franchisor of chiropractic clinics, posted operating highlights and limited financial information for the quarter